Use of cyclic AMP and ascorbic acid to produce dopaminergic neurons from embryonic stem cells
First Claim
1. A method for making dopaminergic neuronal cells from human embryonic stem (hES) cells, comprising:
- a) differentiating hES cells into a neural progenitor cell population in which at least 60% of the cells are Nestin positive;
b) culturing the Nestin positive progenitor cells in a culture medium comprising a neurotrophin, and either cyclic adenosine monophosphate (cAMP) or a compound that elevates intracellular cAMP levels; and
c) harvesting a cell population from the culture medium that comprises neuronal cells expressing tyrosine hydroxylase.
1 Assignment
0 Petitions
Accused Products
Abstract
This disclosure provides improved methods for obtaining populations of dopaminergic neurons from pluripotent stem cells. The process involves taking a population of neural precursor cells derived from a line of human embryonic stem cells, and culturing the cells in a medium that contains a neurotrophin, either cyclic adenosine monophosphate (cAMP) or a compound that elevates intracellular cAMP levels, and optionally an antioxidant such as ascorbic acid. Cell populations have been obtained that contain a high proportion of cells staining for tyrosine hydroxylase, which is a feature of dopaminergic neurons. The neural progenitors and terminally differentiated neurons of this invention can be generated in large quantities for use in drug screening and the treatment of clinically important neurological disorders, such as Parkinson'"'"'s disease.
-
Citations
24 Claims
-
1. A method for making dopaminergic neuronal cells from human embryonic stem (hES) cells, comprising:
-
a) differentiating hES cells into a neural progenitor cell population in which at least 60% of the cells are Nestin positive;
b) culturing the Nestin positive progenitor cells in a culture medium comprising a neurotrophin, and either cyclic adenosine monophosphate (cAMP) or a compound that elevates intracellular cAMP levels; and
c) harvesting a cell population from the culture medium that comprises neuronal cells expressing tyrosine hydroxylase. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
-
-
21. A method for making dopaminergic neuronal cells from human embryonic stem (hES) cells, comprising:
-
a) culturing a neural progenitor cell population derived from an hES cell line in which at least 25% of the cells are MAP-2 positive in a culture medium comprising a neurotrophin, and either cyclic adenosine monophosphate (cAMP) or a compound that elevates intracellular cAMP levels; and
b) harvesting a cell population from the culture medium that comprises neuronal cells expressing tyrosine hydroxylase. - View Dependent Claims (22)
-
-
23. A method for making dopaminergic neuronal cells from human embryonic stem (hES) cells, comprising:
-
a) culturing hES cells in a differentiation medium containing at least one mitogen and a factor selected from neurotrophins, sonic hedge hog, and TGF-β
Superfamily Antagonists;
b) culturing the cells obtained from step a) in a culture medium comprising a neurotrophin, either cyclic adenosine monophosphate (cAMP) or a compound that elevates intracellular cAMP levels, and ascorbic acid; and
c) harvesting a cell population from the culture medium that comprises neuronal cells expressing tyrosine hydroxylase.
-
-
24. A method for making dopaminergic neuronal cells from human embryonic stem (hES) cells, comprising:
-
a) culturing hES cells in a differentiation medium containing at least one mitogen and at least one neurotrophin;
b) culturing the cells obtained from step a) in a culture medium comprising a neurotrophin, cyclic adenosine monophosphate (cAMP), and ascorbic acid; and
c) harvesting a cell population from the culture medium that comprises neuronal cells expressing tyrosine hydroxylase.
-
Specification